Eldridge BBB-B CLO ETFCLOZ

Eldridge’s CLOZ ETF, listed on Nasdaq under ticker CLOZ, is the latest attempt to package collateralised loan obligations rated BBB-B into an exchange-traded wrapper. The fund’s mandate promises exposure to a diversified basket of concentrated loans sliced into BBB-B tranches, a slice of the capital stack that sits just above equity but below investment grade. The issuer’s marketing leans into the “exposure” language, suggesting investors gain efficient, liquid access to a historically opaque corner of credit markets without the filing trail of direct CLO ownership. The reality, however, is closer to a fee-for-structure product where the wrapper’s liquidity does not magically improve the underlying loans’ risk profile. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cloz)

The fund’s expense ratio sits at 0.45% per year, a figure that appears small until you remember it compounds on every dollar invested regardless of the loans’ performance. FINRA’s Fund Analyzer confirms the fee but provides no insight into whether the underlying portfolio’s yield compensates for it. The issuer’s prospectus language is careful to state that the fund “seeks to track” an index of BBB-B CLOs, a phrase that in practice means it will own a static or semi-static basket of tranches selected by an index provider. There is no guarantee the index itself relative strength or that the tranches avoid defaults. (source: FINRA, https://tools.finra.org/fund_analyzer/)

The SEC EDGAR filing record for CLOZ consists of standard regulatory disclosures: the fund’s investment objective, principal risks, and the usual boilerplate about leverage, illiquidity, and potential conflicts of interest. The filings do not disclose the fund’s current holdings, top ten exposures, or the index methodology, leaving investors to trust the issuer’s marketing rather than the documents themselves. The fund’s registration statement (likely S-1) and subsequent amendments are available on SEC EDGAR, but they do not contain revenue, profit, or asset figures specific to the ETF. (source: SEC EDGAR fund search for CLOZ, https://www.sec.gov/edgar/search/#/q=CLOZ)

CLOZ trades on Nasdaq, which provides real-time quotes and basic market data but does not disclose the fund’s average daily volume, bid-ask spreads, or whether the ETF’s liquidity is supported by authorised participants or market makers. The Nasdaq listing confirms the wrapper exists and is tradeable but offers no insight into the actual liquidity of the underlying BBB-B CLO tranches, which are notoriously illiquid even when packaged into an ETF. The chart route on Nasdaq shows ticker-level price action but does not reveal the fund’s net asset value or tracking error versus its benchmark. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cloz)

What remains unproven is the fund’s tracking accuracy, its true expense drag after replication costs, and whether the BBB-B tranche exposure relative strength or lag direct corporate bonds of similar rating once fees and bid-ask frictions are accounted for. The issuer’s marketing materials do not provide a side-by-side comparison with a plain-vanilla high-return bond ETF, leaving the “efficiency” claim unverified. Until the fund publishes its holdings or a third-party performance audit, investors are buying a promise wrapped in a fee. (source: SEC EDGAR fund search for CLOZ, https://www.sec.gov/edgar/search/#/q=CLOZ)